Guy Neff
Gastroenterology · Sarasota, FLNPI 1477510931
Payments from drug & device makers
Across 3,916 payments — averaging $4505.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$7.5M
- Boehringer Ingelheim International GmbH$6.5M
- Madrigal Pharmaceuticals$1.4M
- Gilead$1.2M
- E.r. Squibb & Sons, L.L.C.$370K
- Novartis$180K
- plus $410K from 12 others
Across 3 payments — averaging $1778.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$5K
What the payments were for
- Consulting fees$15,86030%
- Speaking & faculty fees$20,23839%
- Travel & lodging$15,49330%
- Food & beverage$6751%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 155 | $7,532,723 |
| Boehringer Ingelheim International GmbH | 2,852 | $6,549,187 |
| Madrigal Pharmaceuticals | 408 | $1,403,016 |
| Gilead | 251 | $1,199,353 |
| E.r. Squibb & Sons, L.L.C. | 5 | $369,817 |
| Novartis | 6 | $179,665 |
| Intercept Pharmaceuticals, Inc. | 65 | $152,809 |
| Genentech, Inc. | 16 | $84,981 |
| Boehringer Ingelheim RCV GmbH & Co KG | 82 | $59,853 |
| Novo Nordisk AS | 38 | $44,765 |
| Corcept Therapeutics | 11 | $26,860 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $12,721 |
| AbbVie | 9 | $11,076 |
| Ipsen Bioscience Inc. | 2 | $10,306 |
| Intercept Pharma Europe Ltd. | 2 | $4,845 |
| Novo Nordisk | 2 | $1,800 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $49 |
| Eli Lilly | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCALIVA$18,285
How this compares
$17,643,849 in reported general payments places this provider in the 95th percentile of 1,388 gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 54 | $582 |
| Tramadol Hcl | 36 | $60 |
| Alprazolam | 49 | $49 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Sarasota
- Souvik SarkarSarasota$1.2M
- Howard SchwartzTavernier$38.8M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
- Henry LevineOrlando$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.